| D00107 |
Tacrolimus (USP/INN); Tacrolimus hydrate (JP18); Prograf (TN); Protopic (TN) |
(P) unclassified |
| D00142 |
Methotrexate (JP18/USP/INN); Otrexup (TN); Xatmep (TN) |
(P) unclassified |
| D00211 |
Rifampin (USP); Rifampicin (JP18/INN); Rifadin (TN); Rimactane (TN) |
(P) unclassified |
| D00292 |
Dexamethasone (JP18/USP/INN); Decadron (TN); Maxidex (TN) |
(P) unclassified |
| D00293 |
Diazepam (JP18/USP/INN); Diastat (TN); Valium (TN) |
(P) Enzyme: CYP2C19 |
| D00298 |
Digoxin (JP18/USP); Lanoxicaps (TN); Lanoxin (TN) |
(P) unclassified |
| D00350 |
Itraconazole (JP18/USP); Itrizole (TN); Sporanox (TN) |
(P) unclassified |
| D00420 |
Mitotane (JAN/USP/INN); Lysodren (TN) |
(P) unclassified |
| D00435 |
Nevirapine (JAN/USP/INN); Viramune (TN) |
(P) unclassified |
| D00506 |
Phenobarbital (JP18/USP/INN); Luminal (TN) |
(P) unclassified |
| D00512 |
Phenytoin (JP18/USP/INN); Dilantin (TN) |
(P) unclassified |
| D00528 |
Caffeine (USP); Anhydrous caffeine (JP18); Anhydrous caffeine (TN); Respia (TN) |
(P) unclassified |
| D00550 |
Midazolam (JAN/USP/INN); Dormicum (TN); Buccolam (TN); Nayzilam (TN) |
(P) unclassified |
| D00564 |
Warfarin sodium (USP); Coumadin (TN); Jantoven (TN) |
(P) unclassified |
| D00578 |
Voriconazole (JP18/USP/INN); Vfend (TN) |
(P) unclassified |
| D00636 |
Amiodarone hydrochloride (JP18/USP); Ancaron (TN); Cordarone (TN); Nexterone (TN) |
(P) unclassified |
| D00701 |
Phenobarbital sodium (JAN/USP/INN); Luminal sodium (TN) |
(P) unclassified |
| D00831 |
Mefloquine hydrochloride (JP18/USP); Lariam (TN) |
(P) unclassified |
| D00899 |
Nelfinavir mesylate (USAN/INN); Nelfinavir mesilate (JAN); Viracept (TN) |
(P) unclassified |
| D00961 |
Bicalutamide (JP18/USP/INN); Casodex (TN) |
(P) unclassified |
| D01144 |
Prulifloxacin (JAN/INN); Sword (TN) |
(P) unclassified |
| D01167 |
Magnesium oxide (JP18/USP); Magmitt (TN) |
(P) unclassified |
| D01253 |
Clobazam (JAN/USAN/INN); Mystan (TN); Onfi (TN) |
(P) Enzyme: CYP2C19 |
| D01276 |
Atazanavir sulfate (JAN/USAN); Reyataz (TN) |
(CI) unclassified |
| D01280 |
Warfarin potassium (JP18); Athrombin-K (TN) |
(P) unclassified |
| D01418 |
Tamibarotene (JAN/USAN/INN); Am 80; Amnoid (TN) |
(P) unclassified |
| D01441 |
Imatinib mesylate (USAN); Imatinib mesilate (JAN); Gleevec (TN); Glivec (TN) |
(P) unclassified |
| D01745 |
Domperidone (JP18/USAN/INN); Motilium (TN) |
(P) unclassified |
| D01832 |
Modafinil (JAN/USP/INN); Provigil (TN) |
(P) CYP inhibition: CYP2C19 |
| D01896 |
Cilostazol (JP18/USP/INN); Pletal (TN) |
(P) Enzyme: CYP2C19 |
| D01977 |
Gefitinib (JP18/USAN/INN); Iressa (TN) |
(P) unclassified |
| D02103 |
Phenytoin sodium (USP); Phenytoin sodium for injection (JP18); Aleviatin (TN); Dilantin (TN) |
(P) unclassified |
| D02115 |
Methotrexate sodium; Trexall (TN); Rasuvo (TN) |
(P) unclassified |
| D02372 |
Perospirone hydrochloride hydrate (JAN); Lullan (TN) |
(P) unclassified |
| D02484 |
Artemether and lumefantrine; Coartem (TN) |
(P) unclassified |
| D02587 |
Metildigoxin (JP18); Lanirapid (TN) |
(P) unclassified |
| D02691 |
Somatropin (USP/INN); Somatropin (genetical recombination) (JAN); Human growth hormone (JAN); Asellacrin (TN); Humatrope (TN); Nutropin (TN); Omnitrope (TN) |
(P) CYP inhibition: CYP2C19 |
| D02732 |
Pranlukast hydrate (JP18); Onon (TN) |
(P) unclassified |
| D02968 |
Aprepitant (JAN/USP/INN); Aponvie (TN); Emend (TN); Cinvanti (TN) |
(P) unclassified |
| D03106 |
Bexarotene (JAN/USAN/INN); Targretin (TN) |
(P) unclassified |
| D03218 |
Axitinib (JAN/USAN); Inlyta (TN) |
(P) unclassified |
| D03252 |
Bosutinib (USAN) |
(P) unclassified |
| D03257 |
Trastuzumab (USAN/INN); Trastuzumab (genetical recombination) (JAN); Trastuzumab (genetical recombination) [Trastuzumab biosimilar 1] (JAN); Trastuzumab (genetical recombination) [Trastuzumab biosimilar 2] (JAN); Trastuzumab (genetical recombination) [Trastuzumab biosimilar 3] (JAN); Trastuzumab-pkrb; Trastuzumab-anns; Trastuzumab-dkst; Trastuzumab-dttb; Trastuzumab-qyyp; Trastuzumab-anns; Herceptin (TN); Herzuma (TN); Kanjinti (TN); Ogivri (TN); Ontruzant (TN) |
(P) unclassified |
| D03306 |
Calcium polycarbophil (USP); Polycarbophil calcium (JAN); Mitrolan (TN) |
(P) unclassified |
| D03350 |
Canertinib dihydrochloride (USAN) |
(P) unclassified |
| D03455 |
Cetuximab (USAN/INN); Cetuximab (genetical recombination) (JAN); Erbitux (TN) |
(P) unclassified |
| D03658 |
Dasatinib (JAN/INN) |
(P) unclassified |
| D03669 |
Deferasirox (JAN/USAN/INN); Exjade (TN); Jadenu (TN) |
(P) unclassified |
| D04023 |
Erlotinib hydrochloride (JAN/USAN); Tarceva (TN) |
(P) unclassified |
| D04024 |
Lapatinib ditosylate (USAN); Lapatinib tosilate hydrate (JAN); Lapatinib ditosylate monohydrate; Tykerb (TN); Tyverb (TN) |
(P) unclassified |
| D04025 |
Mubritinib (USAN/INN) |
(P) unclassified |
| D04641 |
Istradefylline (JAN/USAN/INN); Nourianz (TN); Nouriast (TN) |
(P) unclassified |
| D04666 |
Lanreotide acetate (JAN/USAN); Somatuline (TN) |
(P) unclassified |
| D04696 |
Lestaurtinib (USAN/INN) |
(P) unclassified |
| D04768 |
Lonafarnib (JAN/USAN/INN); Zokinvy (TN) |
(P) unclassified |
| D05029 |
Midostaurin (JAN/USAN/INN); Rydapt (TN) |
(P) unclassified |
| D05350 |
Panitumumab (USAN/INN); Panitumumab (genetical recombination) (JAN); Vectibix (TN) |
(P) unclassified |
| D05380 |
Pazopanib hydrochloride (JAN/USAN); Votrient (TN) |
(P) unclassified |
| D05399 |
Pelitinib (USAN/INN) |
(P) unclassified |
| D05446 |
Pertuzumab (USAN/INN); Pertuzumab (genetical recombination) (JAN); Perjeta (TN) |
(P) unclassified |
| D05775 |
Rufinamide (JAN/USP/INN); Banzel (TN) |
(P) unclassified |
| D05819 |
Semaxanib (USAN/INN) |
(P) unclassified |
| D05928 |
Stiripentol (JAN/USAN/INN); Diacomit (TN) |
(P) Enzyme: CYP2C19 / CYP inhibition: CYP2C19 |
| D06005 |
Tandutinib (USAN/INN) |
(P) unclassified |
| D06272 |
Sorafenib tosylate (USAN); Sorafenib tosilate (JAN); Nexavar (TN) |
(P) unclassified |
| D06285 |
Vatalanib (USAN/INN) |
(P) unclassified |
| D06402 |
Sunitinib malate (JAN/USAN); Sutent (TN) |
(P) unclassified |
| D06407 |
Vandetanib (JAN/USAN/INN); Caprelsa (TN) |
(P) unclassified |
| D06413 |
Nilotinib hydrochloride hydrate (JAN); Nilotinib monohydrochloride monohydrate; Tasigna (TN) |
(P) unclassified |
| D06414 |
Dasatinib (USAN); Dasatinib hydrate (JAN); Sprycel (TN) |
(P) unclassified |
| D06597 |
Fosaprepitant dimeglumine (USAN); Fosaprepitant meglumine (JAN); Proemend (TN) |
(P) unclassified |
| D06678 |
Motesanib (USAN); AMG 706 |
(P) unclassified |
| D07583 |
Phenytoin and phenobarbital; Aleviatin with phenobarbital (TN) |
(P) unclassified |
| D07595 |
Fosphenytoin sodium hydrate (JAN); Fostoin (TN) |
(P) unclassified |
| D07907 |
Erlotinib (INN) |
(P) unclassified |
| D08066 |
Imatinib (INN); Glamox (TN) |
(P) unclassified |
| D08108 |
Lapatinib (INN) |
(P) unclassified |
| D08279 |
Tozasertib (USAN) |
(P) unclassified |
| D08344 |
Tozasertib lactate (USAN); MK-0457 |
(P) unclassified |
| D08503 |
Toceranib (USAN) |
(P) unclassified |
| D08524 |
Sorafenib (USAN/INN) |
(P) unclassified |
| D08544 |
Toceranib phosphate (USAN) |
(P) unclassified |
| D08552 |
Sunitinib (INN) |
(P) unclassified |
| D08682 |
Warfarin (INN); Warfarine; Choice (TN) |
(P) unclassified |
| D08878 |
Brivanib alaninate (JAN/USAN/INN) |
(P) unclassified |
| D08881 |
Cediranib (USAN/INN) |
(P) unclassified |
| D08883 |
Cediranib maleate (JAN/USAN) |
(P) unclassified |
| D08907 |
Dovitinib lactate (USAN); Dovitinib lactate hydrate (JAN) |
(P) unclassified |
| D08947 |
Motesanib diphosphate (USAN); Motesanib phosphate (JAN) |
(P) unclassified |
| D08950 |
Neratinib (USAN/INN) |
(P) unclassified |
| D08953 |
Nilotinib (USAN/INN) |
(P) unclassified |
| D09347 |
Fostamatinib (USAN) |
(P) unclassified |
| D09348 |
Fostamatinib disodium (USAN); Fostamatinib sodium hydrate (JAN); Fostamatinib disodium hexahydrate; Tavalisse (TN) |
(P) unclassified |
| D09589 |
Brivanib (USAN) |
(P) unclassified |
| D09618 |
Foretinib (USAN/INN) |
(P) unclassified |
| D09635 |
Linifanib (USAN/INN) |
(P) unclassified |
| D09638 |
Lomitapide mesylate (USAN); Lomitapide mesilate (JAN); Juxtapid (TN); Lojuxta (TN) |
(P) unclassified |
| D09664 |
Saracatinib (USAN/INN) |
(P) unclassified |
| D09665 |
Saracatinib difumarate (USAN) |
(P) unclassified |
| D09683 |
Tivozanib (USAN/INN) |
(P) unclassified |
| D09689 |
Varlitinib (USAN/INN) |
(P) unclassified |
| D09690 |
Varlitinib tosylate (USAN) |
(P) unclassified |
| D09724 |
Afatinib (USAN/INN) |
(P) unclassified |
| D09728 |
Bosutinib hydrate (JAN); Bosutinib monohydrate; Bosulif (TN) |
(P) unclassified |
| D09731 |
Crizotinib (JAN/USAN/INN); Xalkori (TN) |
(P) unclassified |
| D09733 |
Afatinib dimaleate (USAN); Afatinib maleate (JAN); Gilotrif (TN); Giotrif (TN) |
(P) unclassified |
| D09799 |
Carotegrast methyl (JAN); Carogra (TN) |
(P) unclassified |
| D09847 |
Metildigoxin (INN); Medigoxin (BAN) |
(P) unclassified |
| D09864 |
Amuvatinib (USAN/INN) |
(P) unclassified |
| D09865 |
Amuvatinib hydrochloride (USAN) |
(P) unclassified |
| D09883 |
Dacomitinib (INN) |
(P) unclassified |
| D09919 |
Lenvatinib (USAN/INN) |
(P) unclassified |
| D09920 |
Lenvatinib mesylate (USAN); Lenvatinib mesilate (JAN); Lenvima (TN) |
(P) unclassified |
| D09945 |
Pegdinetanib (USAN/INN) |
(P) unclassified |
| D09950 |
Ponatinib (USAN/INN) |
(P) unclassified |
| D09951 |
Ponatinib hydrochloride (JAN/USAN); Iclusig (TN) |
(P) unclassified |
| D09955 |
Quizartinib (USAN/INN) |
(P) unclassified |
| D09956 |
Quizartinib dihydrochloride (USAN); Quizartinib hydrochloride (JAN); Vanflyta (TN) |
(P) unclassified |
| D09958 |
Rilpivirine hydrochloride (JAN/USAN); Edurant (TN) |
(CI) unclassified |
| D09980 |
Trastuzumab emtansine (USAN/INN); Trastuzumab emtansine (genetical recombination) (JAN); Ado-trastuzumab emtansine; Kadcyla (TN) |
(P) unclassified |
| D09996 |
Vemurafenib (JAN/USAN/INN); Zelboraf (TN) |
(P) unclassified |
| D10003 |
Hemin (JAN); Normosang (TN); Panhematin (TN) |
(P) unclassified |
| D10018 |
Necitumumab (USAN/INN); Necitumumab (genetical recombination) (JAN); Portrazza (TN) |
(P) unclassified |
| D10062 |
Cabozantinib (USAN); Cabometyx (TN); Cometriq (TN) |
(P) unclassified |
| D10095 |
Cabozantinib s-malate (USAN); Cabozantinib malate (JAN); Cometriq (TN); Cabometyx (TN) |
(P) unclassified |
| D10102 |
Crenolanib (USAN) |
(P) unclassified |
| D10103 |
Crenolanib besylate (USAN) |
(P) unclassified |
| D10104 |
Dabrafenib mesylate (USAN); Dabrafenib mesilate (JAN); Tafinlar (TN) |
(P) unclassified |
| D10137 |
Regorafenib hydrate (JAN); Stivarga (TN) |
(P) unclassified |
| D10138 |
Regorafenib (USAN/INN); Stivarga (TN) |
(P) unclassified |
| D10161 |
Sarilumab (USAN); Sarilumab (genetical receombination) (JAN); Kevzara (TN) |
(P) unclassified |
| D10173 |
Tivantinib (JAN/USAN/INN) |
(P) unclassified |
| D10190 |
Tivozanib hydrochloride (USAN); Tivozanib hydrochloride monohydrate; Fotivda (TN) |
(P) unclassified |
| D10202 |
Bafetinib (USAN) |
(P) unclassified |
| D10218 |
Enzalutamide (JAN/USAN); Xtandi (TN) |
(P) unclassified |
| D10223 |
Ibrutinib (JAN/USAN); Imbruvica (TN) |
(P) unclassified |
| D10224 |
Golvatinib (USAN) |
(P) unclassified |
| D10229 |
Masitinib (INN) |
(P) unclassified |
| D10334 |
Rebastinib (USAN) |
(P) unclassified |
| D10372 |
Palbociclib (JAN/USAN); Ibrance (TN) |
(P) unclassified |
| D10396 |
Nintedanib esylate (USAN); Nintedanib ethanesulfonate (JAN); Ofev (TN) |
(P) unclassified |
| D10399 |
Rebastinib Tosylate (USAN) |
(P) unclassified |
| D10446 |
Margetuximab (USAN/INN); Margetuximab-cmkb; Margenza (TN) |
(P) unclassified |
| D10450 |
Alectinib hydrochloride (JAN); Alecensa (TN) |
(P) unclassified |
| D10465 |
Golvatinib tartrate (USAN) |
(P) unclassified |
| D10466 |
Vonoprazan fumarate (JAN/USAN); Takecab (TN); Voquezna (TN) |
(P) Enzyme: CYP2C19 / Target: ATP4A ATP4B |
| D10481 |
Nintedanib (USAN/INN); Ofev (TN) |
(P) unclassified |
| D10514 |
Dacomitinib (USAN); Dacomitinib hydrate (JAN); Vizimpro (TN) |
(P) unclassified |
| D10542 |
Alectinib (USAN/INN) |
(P) unclassified |
| D10551 |
Ceritinib (JAN/USAN/INN); Zykadia (TN) |
(P) unclassified |
| D10564 |
Amenamevir (JAN/INN); Amenalief (TN) |
(P) unclassified |
| D10566 |
Pasireotide pamoate (JAN); Signifor lar (TN) |
(P) unclassified |
| D10578 |
Ledipasvir and sofosbuvir; Harvoni (TN) |
(P) unclassified |
| D10618 |
Defactinib (USAN/INN) |
(P) unclassified |
| D10619 |
Defactinib hydrochloride (USAN) |
(P) unclassified |
| D10643 |
Isavuconazonium sulfate (JAN/USAN); Cresemba (TN) |
(P) unclassified |
| D10696 |
Capmatinib (USAN/INN) |
(P) unclassified |
| D10709 |
Gilteritinib (USAN/INN) |
(P) unclassified |
| D10730 |
Spebrutinib (USAN/INN) |
(P) unclassified |
| D10731 |
Spebrutinib besylate (USAN) |
(P) unclassified |
| D10762 |
Fosravuconazole L-lysine ethanolate (JAN) |
(P) unclassified |
| D10766 |
Osimertinib mesylate (USAN); Osimertinib mesilate (JAN); Tagrisso (TN) |
(P) unclassified |
| D10774 |
Vonoprazan, amoxicillin and metronidazole; Vonopion (TN) |
(P) Enzyme: CYP2C19 |
| D10775 |
Vonoprazan, amoxicillin and clarithromycin; Vonosap (TN); Voquenza (TN) |
(P) Enzyme: CYP2C19 |
| D10800 |
Gilteritinib fumarate (JAN/USAN); Xospata (TN) |
(P) unclassified |
| D10801 |
Letermovir (JAN/USAN/INN); Prevymis (TN) |
(P) CYP induction: CYP2C19 |
| D10827 |
Sofosbuvir and velpatasvir; Epclusa (TN) |
(P) unclassified |
| D10836 |
Emtricitabine, rilpivirine and tenofovir alafenamide; Odefsey (TN) |
(CI) unclassified |
| D10858 |
Rociletinib (USAN/INN) |
(P) unclassified |
| D10859 |
Olmutinib (USAN/INN) |
(P) unclassified |
| D10862 |
Altiratinib (USAN) |
(P) unclassified |
| D10866 |
Brigatinib (JAN/USAN); Alunbrig (TN) |
(P) unclassified |
| D10886 |
Naquotinib mesylate (USAN); Naquotinib mesilate (JAN) |
(P) unclassified |
| D10891 |
Capmatinib hydrochloride (USAN); Capmatinib hydrochloride hydrate (JAN); Tabrecta (TN) |
(P) unclassified |
| D10893 |
Acalabrutinib (JAN/USAN/INN); Calquence (TN) |
(P) unclassified |
| D10898 |
Neratinib maleate; Nerlynx (TN) |
(P) unclassified |
| D10926 |
Entrectinib (JAN/USAN/INN); Rozlytrek (TN) |
(P) unclassified |
| D10927 |
Erdafitinib (JAN/USAN/INN); Balversa (TN) |
(P) unclassified |
| D10958 |
Naquotinib (USAN/INN) |
(P) unclassified |
| D10990 |
Somatrogon (USAN/INN); Somatrogon (genetical recombination) (JAN); Somatrogon-ghla; Ngenla (TN) |
(P) unclassified |
| D11012 |
Lorlatinib (JAN/USAN/INN); Lorbrena (TN) |
(P) unclassified |
| D11040 |
Apalutamide (JAN/INN); Erleada (TN) |
(P) CYP induction: CYP2C19 |
| D11062 |
Osilodrostat phosphate (JAN/USAN); Isturisa (TN) |
(P) unclassified |
| D11070 |
Tirabrutinib hydrochloride (JAN/USAN); Velexbru (TN) |
(P) unclassified |
| D11073 |
Tepotinib hydrochloride (USAN); Tepotinib hydrochloride hydrate (JAN); Tepmetko (TN) |
(P) unclassified |
| D11115 |
Olmutinib hydrochloride (USAN) |
(P) unclassified |
| D11136 |
Glesatinib (USAN/INN) |
(P) unclassified |
| D11137 |
Larotrectinib (USAN/INN) |
(P) unclassified |
| D11138 |
Larotrectinib sulfate (JAN/USAN); Vitrakvi (TN) |
(P) unclassified |
| D11139 |
Savolitinib (USAN/INN) |
(P) unclassified |
| D11140 |
Sitravatinib (USAN/INN) |
(P) unclassified |
| D11141 |
Tucatinib (USAN/INN); Tukysa (TN) |
(P) unclassified |
| D11194 |
Somapacitan (USAN/INN); Somapacitan (genetical recombination) (JAN); Somapacitan-beco; Sogroya (TN) |
(P) unclassified |
| D11209 |
Entospletinib (USAN/INN) |
(P) unclassified |
| D11251 |
Icotinib |
(P) unclassified |
| D11279 |
Avapritinib (USAN/INN); Ayvakit (TN); Ayvakyt (TN) |
(P) unclassified |
| D11282 |
Dolutegravir sodium and rilpivirine hydrochloride; Juluca (TN) |
(CI) unclassified |
| D11288 |
Rivoceranib (USAN/INN); Apatinib |
(P) unclassified |
| D11289 |
Rivoceranib mesylate (USAN); Alitan (TN) |
(P) unclassified |
| D11346 |
Ensartinib (USAN) |
(P) unclassified |
| D11353 |
Ripretinib (USAN); Qinlock (TN) |
(P) unclassified |
| D11356 |
Ensartinib hydrochloride (USAN) |
(P) unclassified |
| D11368 |
Mavelertinib (USAN/INN) |
(P) unclassified |
| D11370 |
Fosnetupitant chloride hydrochloride (JAN/USAN); Arokaris (TN) |
(P) unclassified |
| D11375 |
Trastuzumab duocarmazine (USAN/INN) |
(P) unclassified |
| D11403 |
Asciminib (USAN/INN) |
(P) unclassified |
| D11404 |
Asciminib hydrochloride (JAN/USAN); Scemblix (TN) |
(P) unclassified |
| D11417 |
Pemigatinib (JAN/USAN/INN); Pemazyre (TN) |
(P) unclassified |
| D11422 |
Zanubrutinib (JAN/USAN/INN); Brukinsa (TN) |
(P) unclassified |
| D11428 |
Vecabrutinib (USAN/INN) |
(P) unclassified |
| D11430 |
Nazartinib (USAN/INN) |
(P) unclassified |
| D11434 |
Nazartinib mesylate (USAN); Nazartinib mesylate trihydrate |
(P) unclassified |
| D11438 |
Bemcentinib (USAN/INN) |
(P) unclassified |
| D11454 |
Repotrectinib (JAN/USAN); Augtyro (TN) |
(P) unclassified |
| D11457 |
Fenebrutinib (USAN/INN) |
(P) unclassified |
| D11461 |
Derazantinib hydrochloride (USAN); Derazantinib dihydrochlororide |
(P) unclassified |
| D11478 |
Branebrutinib (USAN) |
(P) unclassified |
| D11485 |
Tazemetostat hydrobromide (JAN/USAN); Tazverik (TN) |
(P) unclassified |
| D11502 |
Vecabrutinib succinate (USAN) |
(P) unclassified |
| D11529 |
Trastuzumab deruxtecan (USAN/INN); Trastuzumab deruxtecan (genetical recombination) (JAN); Fam-trastuzumab deruxtecan-nxki; Enhertu (TN) |
(P) unclassified |
| D11541 |
Sitravatinib malate (USAN) |
(P) unclassified |
| D11560 |
Trastuzumab and hyaluronidase; Trastuzumab and hyaluronidase-oysk; Herceptin hylecta (TN) |
(P) unclassified |
| D11589 |
Infigratinib (USAN/INN) |
(P) unclassified |
| D11611 |
Infigratinib phosphate (USAN); Truseltiq (TN) |
(P) unclassified |
| D11674 |
Berotralstat hydrochloride (JAN/USAN); Orladeyo (TN) |
(P) unclassified |
| D11676 |
Gusacitinib (USAN/INN) |
(P) unclassified |
| D11677 |
Gusacitinib hydrochloride (USAN) |
(P) unclassified |
| D11712 |
Pralsetinib (USAN/INN); Gavreto (TN) |
(P) unclassified |
| D11713 |
Selpercatinib (JAN/USAN/INN); Retevmo (TN) |
(P) unclassified |
| D11717 |
Tepotinib (USAN/INN) |
(P) unclassified |
| D11720 |
Acalabrutinib maleate (USAN) |
(P) unclassified |
| D11725 |
Futibatinib (JAN/USAN/INN); Lytgobi (TN) |
(P) unclassified |
| D11732 |
Dubermatinib (USAN/INN) |
(P) unclassified |
| D11733 |
Dubermatinib tartrate (USAN) |
(P) unclassified |
| D11737 |
Fisogatinib (USAN/INN) |
(P) unclassified |
| D11768 |
Pacritinib (USAN/INN); Vonjo (TN) |
(P) unclassified |
| D11772 |
Tesevatinib (USAN/INN) |
(P) unclassified |
| D11773 |
Tesevatinib tosylate (USAN) |
(P) unclassified |
| D11786 |
Vodobatinib (USAN) |
(P) unclassified |
| D11804 |
Aspirin and vonoprazan; Cabpirin (TN) |
(P) unclassified |
| D11816 |
Belumosudil mesylate (USAN); Belumosudil mesilate (JAN); Rezurock (TN) |
(P) unclassified |
| D11873 |
Rilzabrutinib (JAN/USAN/INN) |
(P) unclassified |
| D11894 |
Amivantamab (USAN/INN); Amivantamab (genetical recombination) (JAN); Amivantamab-vmjw; Rybrevant (TN) |
(P) unclassified |
| D11920 |
Pimitespib (JAN); Jeselhy (TN) |
(P) unclassified |
| D11969 |
Mobocertinib succinate (JAN); Exkivity (TN) |
(P) unclassified |
| D11970 |
Ritlecitinib tosylate (USAN); Ritlecitinib tosilate (JAN); Litfulo (TN) |
(P) unclassified |
| D11977 |
Fruquintinib (JAN/USAN); Fruzaqla (TN) |
(P) Enzyme: CYP2C19 |
| D11980 |
Lazertinib (USAN) |
(P) unclassified |
| D12001 |
Mobocertinib (USAN/INN) |
(P) unclassified |
| D12015 |
St. John's wort; SJW |
(P) unclassified |
| D12050 |
Pirtobrutinib (JAN/USAN); Jaypirca (TN) |
(P) unclassified |
| D12055 |
Sotorasib (JAN/USAN); Lumakras (TN) |
(P) unclassified |
| D12158 |
Elsubrutinib (USAN/INN) |
(P) unclassified |
| D12160 |
Orelabrutinib (USAN/INN) |
(P) unclassified |
| D12213 |
Tolebrutinib (JAN/USAN/INN) |
(P) unclassified |
| D12245 |
Lazertinib mesilate hydrate (JAN) |
(P) unclassified |
| D12258 |
Aumolertinib (USAN/INN) |
(P) unclassified |
| D12259 |
Aumolertinib mesylate (USAN) |
(P) unclassified |
| D12285 |
Remibrutinib (JAN/USAN/INN) |
(P) unclassified |
| D12330 |
Zeteletinib (USAN) |
(P) unclassified |
| D12331 |
Zeteletinib adipate (USAN) |
(P) unclassified |
| D12354 |
Pralsetinib hydrate (JAN) |
(P) unclassified |
| D12363 |
Taletrectinib (USAN/INN) |
(P) unclassified |
| D12364 |
Taletrectinib adipate (USAN) |
(P) unclassified |
| D12383 |
Edralbrutinib (USAN/INN) |
(P) unclassified |
| D12404 |
Tasurgratinib (INN) |
(P) unclassified |
| D12405 |
Tasurgratinib succinate (JAN) |
(P) unclassified |
| D12432 |
Zurletrectinib (USAN) |
(P) unclassified |
| D12442 |
Tucatinib ethanolate (JAN); Tucatinib hemiethanolate |
(P) unclassified |
| D12444 |
Nilotinib hydrochloride dihydrate (JAN) |
(P) unclassified |
| D12457 |
Tuxobertinib (USAN/INN) |
(P) unclassified |
| D12467 |
Evobrutinib (USAN/INN) |
(P) unclassified |
| D12476 |
Tuspetinib (USAN/INN) |
(P) unclassified |
| D12489 |
Atuzabrutinib (USAN/INN) |
(P) unclassified |
| D12504 |
Nemtabrutinib (USAN/INN) |
(P) unclassified |
| D12506 |
Sunvozertinib (USAN/INN) |
(P) unclassified |
| D12526 |
Catequentinib (USAN/INN); Anlotinib |
(P) unclassified |
| D12537 |
Catequentinib hydrochloride (USAN) |
(P) unclassified |
| D12540 |
Briquilimab (USAN/INN) |
(P) unclassified |
| D12557 |
Elzovantinib (USAN/INN) |
(P) unclassified |
| D12559 |
Enbezotinib (USAN/INN) |
(P) unclassified |
| D12586 |
Mifepristone and misoprostol; Mefeego (TN) |
(P) unclassified |
| D12594 |
Tirabrutinib (USAN/INN) |
(P) unclassified |
| D12600 |
Bezuclastinib (USAN/INN) |
(P) unclassified |
| D12609 |
Dasatinib laurylsulfate (USAN) |
(P) unclassified |
| D12646 |
Paltimatrectinib (USAN/INN) |
(P) unclassified |
| D12650 |
Zanzalintinib (USAN/INN) |
(P) unclassified |
| D12651 |
Zanzalintinib fumarate (USAN) |
(P) unclassified |
| D12704 |
Acalabrutinib maleate hydrate (JAN); Acalabrutinib maleate monohydrate |
(P) unclassified |
| D12705 |
Gumarontinib hydrate (JAN) |
(P) unclassified |
| D12730 |
Tigozertinib (USAN) |
(P) unclassified |
| D12828 |
Risvodetinib (USAN/INN) |
(P) unclassified |
| D12829 |
Risvodetinib succinate (USAN) |
(P) unclassified |
| D12831 |
Naporafenib (USAN/INN) |
(P) unclassified |
| D12854 |
Nilotinib laurylsulfate (USAN) |
(P) unclassified |
| D12859 |
Pebezertinib (USAN) |
(P) unclassified |
